Shinhan Investment: “Samsung Bio’s volatility is high due to labor-management negotiations… target price ↓”

(Seoul = Yonhap News) Reporter Go Eun-ji = Shinhan Investment & Securities said on the 1st about Samsung BioLogics [207940], “The volatility of future profitability has increased due to labor-management negotiations.”